John W. Jones Jr.

John W. Jones Jr.


Philadelphia, PA
Phone: 215.981.4706    Fax: 215.981.4750

Mr. Jones’ additional representative engagements include the following:


  • counseling financial sponsors and strategic investors on transactional and health care regulatory issues impacting mergers, acquisitions and dispositions and private placements
  • establishing buy-sell arrangements for various corporations and partnerships, including health care providers and suppliers
  • structuring strategic alliances, partnering arrangements and collaborations both in traditional health care and biotechnology space
  • advising start-ups and emerging health care businesses on corporate formation, structure and governance issues
  • advising boards of directors and management on investments, including asset acquisition and company growth, company life cycle issues and exit strategies.

Health Care - Transactional/Regulatory

  • counseling largest national outpatient pharmacy management company on equity investment by Welsh Carson and Walgreen Co.
  • counseling one of the largest institutional pharmacies on sale transaction
  • counseling Summit Health in its combination with WellSpan
  • counseling private equity sponsor in connection with acquisition of Comprehensive Pharmacy Services
  • counseling hospitals on affiliations, acquisitions and dispositions, including the recent affiliation of Hanover Healthcare PLUS, a community health care network in central Pennsylvania that includes the 93-bed Hanover Hospital, in its affiliation with UPMC Pinnacle, the largest health system in the state
  • counseling health systems, physician groups, long-term care facilities, and other providers on regulatory matters, including fraud and abuse, Stark, facility licensure and operations, reimbursement, including Medicare and Medicaid payment, managed care contracting, physician credentialing and termination, and contract issues, including exclusive contracts
  • counseling private equity fund regarding exit strategies and disposition of equity interest in managed care organization joint venture
  • advising physician groups in establishing independent physician association, hospital-physician joint ventures, provider networks, multi-service organizations and ancillary service corporations
  • counseling pharmaceutical manufacturers regarding fraud and abuse issues, including those presented under sales and marketing arrangements, consulting agreements and arrangements with health care professionals
  • advising ASCs, specialty hospitals and outpatient diagnostic centers on regulatory compliance issues under federal and state fraud and abuse laws (including the federal Anti-Kickback Statute), anti-referral laws (including Stark), licensure and securities laws arising from physician and non-physician, including hospital, ownership of these centers and related real estate acquired through a private offering of partnership interests
  • advising product developer on health care regulatory issues through acquisition, private placement, public offering and commercialization matters
  • counseling suppliers and vendors in connection with fraud and abuse and health care regulatory issues impacting their businesses and arrangements with other health care organizations and individual providers
  • advising hospitals and other health care organizations in connection with establishing and/or joining group purchasing organizations
  • advising public medical transcription services company on health care regulatory issues impacting its business, including issues under the federal Anti-Kickback Statute and civil monetary penalties law
  • counseling rehabilitation center on formation and structural issues and state and federal health care regulations, including fraud and abuse, anti-referral laws, professional licensure regulations and fee splitting statutes
  • representing hospitals and health systems in connection with managed care payment issues, standard of care, and utilization review procedures
  • assisting health systems, physicians and other providers in formulating and executing managed care business strategies, purchase and sale of physician practices, formation and operation of ancillary joint ventures, and mergers and acquisitions
  • counseling private equity fund on health care regulatory issues impacting disposition of equity interest in group purchasing organization
  • counseling private equity fund on health care regulatory issues impacting acquisition of third-party administrator and underwriting and claims services company add-on
  • counseling medical device manufacturer of health care regulatory issues in connection with initial public offering
  • counseling physician and non-physician investors in multi-specialty ASC private placement
  • advising health care staffing company regarding structure, formation and contractual issues, as well as health care regulatory and malpractice matters
  • counseling second largest dialysis provider in the world on payment and reimbursement issues under government and commercial payment programs
  • advising lenders in connection with certain health care regulatory issues (including Stark, fraud and abuse and HIPAA) impacting acquisitions and joint ventures
  • counseling largest long-term care pharmacy GPO on fraud and abuse issues, safe harbor regulations, and regulatory issues impacting its relationships with other members in the medical supply chain, including manufacturers, suppliers and pharmacies
  • advising Medicare Part D pharmacy network manager on rebate, discount and PDP issues under Medicare Prescription Drug, Improvement, and Modernization Act of 2003
  • counseling multi-specialty physician group on development of specialty hospital and private placement
  • counseling national retail and long-term care pharmacy chain regarding state and federal health care regulatory issues impacting its business and negotiate and draft agreements with vendors and suppliers
  • counseling private multi-site radiology practice on federal and state fraud and abuse, Stark, fee splitting, licensure and government and private payor reimbursement issues
  • advising providers, including hospitals, physician groups and medical device companies on billing and claims issues, draft corporate compliance programs and procedures and assist with implementing plan and monitoring compliance
  • advising manufacturers, medical device companies, physician practice groups, hospitals and other providers and suppliers on the federal Anti-Kickback Statute and Stark (and safe harbors) in connection with marketing programs, physician recruitment deals and discount and rebate arrangements
  • counseling nonprofit hospital on disposition of its equity interest in cancer center
  • advising specialty multi-physician groups on fraud and abuse and marketing guidelines, including structuring plans and programs under civil monetary penalties law and federal Anti-Kickback Statute
  • counseling physician and non-physician investors in connection with MRI joint venture private placement.

Life Sciences

  • counseling biotech and manufacturers in life sciences space on wholesale distribution and GPO contracting
  • counseling emerging life science business on raising funds in private placement and additional rounds of financing
  • advising research organizations on indemnification, regulatory compliance and safe harbor issues under fraud and abuse and anti-referral laws
  • counseling biotechnology companies on strategic alliances and partnering arrangements with “big pharma”
  • counseling academic institutions, research organizations and biotechnology companies on clinical research issues
  • counseling research sponsors in connection with clinical trials, research and development procedures and compliance with FDA and HIPAA regulations
  • drafting clinical trial documents and agreements, including master services agreements, clinical study agreements, protocols, agreements with CROs, confidentiality agreements, informed consent and authorization forms
  • preparing and negotiate collaborative research agreements between researchers and academic institutions.

Privacy, Security and Information Technology

  • advising physician network on data use rights and monetization with pharma manufacturers
  • advising health care systems, providers and vendors in connection with interpretation and implementation of HIPAA privacy, security and transaction and code set regulations, including development of privacy policies, notices, authorizations, and business associate and data use agreements
  • assisting software vendors in structuring and developing tools for transactions and claims processing and electronically exchanging protected health information in compliance with HIPAA and development of direct data entry systems
  • assisting in structuring and developing of systems (including debit card payment systems) for health care payment in compliance with HIPAA
  • counseling hospitals and health systems, providers and suppliers on e-commerce issues, including health care regulatory issues (such as fraud and abuse) impacting Web-site development and hosting arrangements
  • advising parties concerning complex commercial transactions involving research and development, product launch and product life cycle
  • advising vendors on development and commercialization of technology innovations, including disease management, charity care, prescription drug plan and electronic health records tools
  • structuring business process outsourcing transactions, including accounting, billing and practice management
  • advising software vendors on HIPAA and state law privacy and confidentiality compliance issues impacting electronic health records and the nuances presented by HIV/AIDS, mental health and drug and alcohol records
  • assisting CROs and product and device manufacturers in development of protocols, research and investigator agreements and informed consent and authorizations in compliance with HIPAA
  • counseling educational institutions regarding obligations under HIPAA privacy regulations
  • advising health care systems on privacy and security aspects of computer systems, networks and data, including HIPAA review and drafting policies and procedures in connection with use of technology
  • counseling hospitals and physicians on telemedicine, including reimbursement, licensure and malpractice issues as well as privacy and other legal issues presented by electronic medical communications.


  • J.D., Dickinson School of Law, 1997,  associate editor, Dickinson Journal of International Law; received the D. Arthur Magaziner Human Services Award, Jack M. Mumford Memorial Health Law Scholarship, the Monroe E. Trout Law and Medicine Award, the Excellence for the Future, Consumer Protection Award and the Excellence for the Future, State Securities Regulation Award
  • M.S.W., Health Policy and Administration, University of Pennsylvania, 1997
  • B.A., Criminal Justice, cum laude, University of Delaware, 1993

Bar Admissions

  • Pennsylvania

Court Admissions

  • U.S. District Court, Middle District of Pennsylvania

Practice Areas

Data protection laws have changed, so we have revised our Privacy Policy.